XNAS · SMMT

+0.62% · +$0.1100 · Vol 13.0M

Market closed · last close 4:00 PM ET · price as of 19:49:18 ET

Summit Therapeutics Inc. Common Stock

PHARMACEUTICAL PREPARATIONS

$17.83

Card

Relationship Map

Follow $SMMT

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $SMMT by email

Veridion Score

BETALOW CONF · 4 of 6 factors measured

Fri Sep 18 · last completed session · Markets closed · resumes Mon 9:30 ET · SMMT

Methodology

Earnings absence reason unknown · Analyst data unavailable at compute time

SMMT

Summit Therapeutics Inc. Common Stock

Fri Sep 18 · last completed session · Markets closed · resumes Mon 9:30 ET

51/100

Middle range

Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

51/ 100

Veridion Score

Middle range · LOW confidence · 4 of 6 factors measured

Sovereign · $25/mo

See why this score moved.

· Factor breakdown with raw signals
· Day-over-day delta + driver
· Factor coverage readout
· Valuation · hype · market flow
· Pro Chart event markers
· Score history + alerts

Start Sovereign · $25/mo →

Cancel anytime · or Reserve · $79/mo

Confidence: LOW · 4 of 6 factors measured · Fri Sep 18 · last completed session · Markets closed · resumes Mon 9:30 ET

Share on X →

Veridion Score History · 90D

AI Analysis

Sovereign

Why is SMMT moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.

Catalyst calendar

What can move SMMT next.

Earnings, ratings, disclosures, volume, and score-history events. Every row needs a dated receipt.

Coverage building

No dated catalysts found for SMMT in the current source window. The page stays empty rather than inventing an event without a receipt.

About Summit Therapeutics Inc. Common Stock

PHARMACEUTICAL PREPARATIONS

Listed since

2015

Employees

265

Country

Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases. Its CDI (Clostridiodes difficile infection) product candidate is ridinilazole, an orally administered small molecule antibiotic. It has two geographical segments: the United States and the United Kingdom.

Company website →

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open

$17.73

Day high

$17.87

Day low

$17.31

Previous close

$17.72

52W high

$26.38

-32.41% from high

52W low

$12.43

39% of range

Market cap

$14.1B

EPS

$-1.4400

Beta

1.58

Shares out

797.7M

Volume

13M

2.06× rel vol

Avg volume

6.3M

VWAP

$17.79

Price history computed in-house

+1.60%

+43.44%

+29.67%

-5.61%

YTD

+1.94%

SMA 50 $14.66 · above

SMA 200 $16.43 · above

52W position 39%

SMMT overview

Veridion Score

Registered · 2026-09-18

4 of 6 factors measured

Latest receipt rows

No recent disclosure on file.

13F holders

None on file

Relationship mapTrace receipt-backed holders and filings around SMMT.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.

SEC Form 4 ledger

SMMT insider activity

Summit Therapeutics Inc. Common Stock

Score

Not evaluated

Pressure

Not evaluated

Filings

Buys / sells

0 / 0

Net value

Not evaluated

Insiders

Cluster

Not covered: this ticker is outside our Form 4 ingest scope — we have not looked

Net pressure

Not evaluated: no value-bearing Form 4 rows are loaded.

Convergence not evaluated

No value-bearing Form 4 rows are loaded, so cross-source convergence is not evaluated.

Form 4 evidence state

Not covered: this ticker is outside our Form 4 ingest scope — we have not looked.

Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology

Public disclosures

Congress activity in SMMT

Congress tracker Open ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for SMMT in the cached public ledger.

Federal contracts

SMMT contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed

Refresh interval: 12hSource: Federal contract awards

No federal contracts on file for SMMT in this window.

Lobbying spend

SMMT lobbying filings, year to date.

Registered lobbying filings matched to Summit Therapeutics Inc. Common Stock.

Not disclosed

Refresh interval: 12hSource: LDA disclosure filings

No lobbying filings on file for SMMT in this window.

Analyst ratings

Sovereign unlock shows live analyst consensus for SMMT.

Options

Sovereign unlock shows live options positioning for SMMT.

Related tickers

Cross-references from this score page.

Apprentice · 1 rail

Similar headline score

Nearest public composite scores. Factor similarity requires Sovereign.

Methodology

No related ticker met the data requirements for this rail.

Follow $SMMT

Why is SMMT moving today?

What can move SMMT next.

SMMT overview

Related filings and maps

SMMT insider activity

SMMT contract awards, year to date.

SMMT lobbying filings, year to date.

Cross-references from this score page.

What can move SMMT next.

SMMT insider activity

Cross-references from this score page.